Dr. David Ross Karp, MD

Dr. Karp practices at University of Texas Southwestern Medical Center at Dallas in Dallas, Texas.

Dr. Karp's NPI, 1326007444, was assigned on March 18, 2006. Dr. Karp graduated from WashU Medicine in 1984. Dr. Karp's Texas license number on file is H9655.

Dr. Karp's primary practice is University of Texas Southwestern Medical Center at Dallas, at 2001 Inwood Rd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-0624.

Dr. Karp's primary practice is University of Texas Southwestern Medical Center at Dallas in Dallas, Texas. Dr. Karp is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Karp to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karp practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Karp's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Karp is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Karp's licenses on file in 2 states: Texas and Maryland.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, lupus, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Karp treats.

CMS data shows 147 Medicare services from Dr. Karp across 4 procedure codes in 2024, for 98 Medicare patients. Medicare paid $9,525 for them. Every service was in an office.

CMS counts 98 Medicare patients who saw Dr. Karp in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have arthritis, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karp's median patient age at 58, with 71% women.

In 2024, Dr. Karp wrote 587 Medicare Part D claims for 80 patients. 69% of them were for generic drugs. CMS names the drug for 432 of them, across 16 drugs with 11 or more claims each, at $647,210 in total drug cost. In 2023, CMS named 339 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Karp for performance year 2024, reported as part of a group. Dr. Karp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karp as offering telehealth.

Dmand AI links 126 papers to Dr. Karp, published from 2006 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Lupus Erythematosus, Systemic, Autoantibodies and Immunoglobulin G. Dr. Karp has published most often in J Immunol. Dr. Karp's most frequent co-authors are Nancy J. Olsen, MD, Judith A. James, MD, PhD and Bonnie Lee Bermas, MD.

Dmand AI links Dr. Karp to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Lupus Erythematosus, Systemic, Connective Tissue Diseases and Arthritis, Rheumatoid. Open Payments lists research payments to Dr. Karp that name 1 trial.

CMS Open Payments shows 8 general payments to Dr. Karp from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Sanofi and Genzyme US Companies paid the most, $1,125. It also lists 1 research payment totaling $28,360 in 2021, naming 1 clinical trial.

Dmand AI lists 5 awards for Dr. Karp, most recently Regional Top Doctor in 2014.

Dr. Karp graduated from WashU Medicine in 1984. Dr. Karp is a member of ACP and ACR.

Dr. Karp is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.